{"title": "", "body": "Aortic stenosis, 677-685, 679f cardiac catheterization in, 682-683, 682t diagnosis of, 681-683, 681f, 682t echocardiography in, 138-139, 139f, 681-682 in pregnancy, 1706 low-gradient, low-output, 683 240-242, 240t, 241f respiratory, 235-238, 235t, 237f, 237t, 239f in acute lung injury, 193-194, 194f in alveolar hypoventilation, 827 in ARDS, 193-194, 194f in brain death, 1333 240-242, 240t, 241f respiratory, 235-238, 235t, 237f, 237t, 239f in acute lung injury, 193-194, 194f in alveolar hypoventilation, 827 in ARDS, 193-194, 194f in brain death, -1335 240-242, 240t, 241f respiratory, 235-238, 235t, 237f, 237t, 239f in acute lung injury, 193-194, 194f in alveolar hypoventilation, 827 in ARDS, 193-194, 194f in brain death, , 1334b Baby lung, in mechanical ventilation, 191-192, 193, 194 Bacillus anthracis, 1156 -1157 Bacteremia, 1143 -1145 diarrhea and, 1149 meningococcal, 1143 nosocomial intravascular device-related, [1024] [1025] [1026] [1027] [1028] [1029] [1030] [1031] [1032] [1033] [1034] [1143] [1144] . See also Bloodstream infections, intravascular device-related microbiology of, 1008t risk factors for, 1008t pneumococcal, 1143-1145 staphylococcal, 1145 Bacterial culture, specimen collection for bronchoalveolar lavage in, 208-211 protected brushing in, 208-211 Bacterial endocarditis, 1140 -1142 , 1141t Bacterial index, in pneumonia, 210 Bacterial meningitis, 1133 -1137 Barbiturates for anxiety, 331, 331t, 333 for status epilepticus, 1378f, 1379b, 1380 overdose of, 1321t Barotrauma, pulmonary, 951t, 955. See also Pneumothorax in asthma, 805 ventilator-associated, 169-170, 170f, 182, 191, 192-193, 953-954, 953f Barrier precautions, 1022 , 1030 , 194-195, 199 in head trauma, 281, 282, 282f, 1386, 1387, 1387t in [154] [155] 154t, [165] [166] [167] 166b, 167 assist pressure control, 156, 156t, 159, 159t, 160f assist volume control, 156, 156t, 159, 159t, 160f baby lung in, [191] [192] 193, 194 bilevel, [161] [162] 162f biologically variable, [164] [165] [223] [224] [225] 206 circuit compressible volume in, 168 common problems in, [33] [34] [168] [169] [170] [171] [169] [170] 170f, 182, 191, [192] [193] [953] [954] 953f decreased cardiac output, 169 gastrointestinal bleeding, 170 nosocomial infections, 170 physiologic basis of, [192] [193] [170] [171] 156, 156t, 159t, 160f, 161 CPAP, [163] [164] 164f in , 191-213, 780-783, 781b, 782b, 783f adjuncts to, 200 baby lung in, 191-192, 193, 194 barotrauma in, 191 chest wall elastance and, 194 extracorporeal support, 200 gas exchange in, 193-194, 194f historical perspective on, 191-192 individualization of, 198-199 inspiratory-to-expiratory ratio in, 198 lung injury severity assessment in, 194-195, 194f, 195f lung protective strategy in, 191 lung recruitability in, 194-195, 195f overview of, 191 PEEP in, 197-198, 197t physiologic basis of, 192-193 respiratory mechanics in, 194 respiratory rate in, 198 tidal volume in, 195-197, 196f, 196t, 226 ventilator settings in, 195-198 volutrauma in, 191, 238 weaning in, 199 in asthma, 802-806 in cancer, 1683 in inhalation injury, 980 in obstructive airway disease adaptive support ventilation in, 187, 187f air trapping in, [178] [179] 178f, 179f airway pressure release ventilation in, [178] [179] 179f, [180] [181] 180f, 181f bilevel ventilation in, 186 CPAP, [185] [186] 186f 165-166, 166-167 PEEP in, 154 auto-PEEP and, 157, 158, 178-179, 179f, 180-181, 180f, 181f, 225 intrinsic, 226-227, 226f physiologic basis of, 192-193 physiologic effects of, 155 pneumonia in, 355, 1034 -1040 ventilation, 154, 156, 156t, 159t, 160-161, 160f technical aspects of, 153-154 tidal volume in, 195-197, 196f, 196t, 223-225, 226 time-cycled breaths in, 157-158 tracheal intubation in, 21-30 . See also Tracheal intubation vs. tracheostomy, [257] [258] [257] [258] [259] [260] 259f, 260f. See also Tracheostomy transpulmonary pressure in, [192] [193] [156] [157] ineffective , -related, 1120 , 1123t, 1126 -1127 treatment of, 1095t, 1097 , 1123t cytomegalovirus, HIV-related, 1125t, 1126 -1127 HIV-related, 1120 , 1123t, 1125t, 1126 -1127 timing of, -associated, 169-170, 170f, 182, 191, 192-193, 953-954 Pneumothorax ex vacuo, 955 P(A-a)O 2 , in shunt calculation, 248, 249t Poiseuille's law, 274 Poisoning/overdose, 1453 -1473 acetaminophen, 1459 -1460 , 1459t, 1588t alcohol, 1322t, 1460 -1462 , 1461t amphetamine/methamphetamine, 1462 antidepressant, 1316t, 1322 , 1466 -1467 , 1471 -1472 antidotes for, 1316 benzodiazepine, 1463 beta blocker, 1463 -1464 calcium channel blocker, 1464 carbamate, 1470 -1471 , 1470t carbon monoxide, 976, 976t, 981, 1320 , 1321t, 1427 , 1464 -1465 . See also Inhalation injury coma in, 1320 diagnosis of, 978, 978f in burn patients, 1427 systemic effects of, 981 cholinesterase, 1470 -1471 , 1470t cocaine, 1321t, 1465 , 1465t coma in, 1316 , 1318b , 1319 , 1320 , 1321t-1322t cyanide, 970, 978, 981-982, 1465 -1466 diagnosis of, 1455 -1457 digoxin, 1467 -1468 enhanced elimination in, 1458 -1459 Poisoning/overdose-cont'd ethylene glycol, 1322t, 1460 -1462 , 1461t gamma hydroxybutyrate, 1468 gastrointestinal decontamination in, 1457 -1458 herbal preparations, 1472 , 1472t history in, 1455 isoniazid, 1468 laboratory fi ndings in, 1456 -1457 lithium, 1322t, 1468 -1469 mushroom, liver failure in, 1587 opioid, 1316 , 1321t, 1457t, 1469 -1470 organophosphate, 1470 -1471 , 1470t physical examination in, 1455 -1456 , 1456t qualitative drug screens in, 1456 -1457 resuscitation and stabilization in, 1455 , 1455b tox screens in, 1456 -1457 toxicokinetics/pharmacokinetics in, 1453 -1455 toxidromes in, 1456 , 1457t valproic acid, 1472 1705 -1706 HELLP syndrome in, 1585 , 1702 -1703 , 1702t hemodynamic monitoring in, 1700 hemorrhage in, 1702t, 1703 -1704 hypertension in, 1701 -1702 , 1701f, 1702t imaging studies in, 1699 liver failure in, 1584 -1585 mechanical ventilation in, 1701 neuromuscular blockade in, 1700 nutrition in, 1698 -1699 physiologic changes in, 1697 -1698 , 1698b , 1699f pneumothorax in, 960 preeclampsia/eclampsia in, 1701 -1702 , 1701f, 1702t pulmonary embolism in, 1704t, 1705 805 ventilator-associated, 169-170, 170f, 182, 191, 192-193, 953- 1683-1684 in pregnancy, 1704-1705 management of, 445-450, 446f, 448f, 449t, 1277, 1277f antibiotics in, 446, 446f cardiovascular support in, 447-450, 448f corticosteroids in, 450 early resuscitation in, 446-447 general principles in, 445-446 microcirculatory dysfunction in, 443-444, 444f "}